Funding Details
- Awarder
- SOSV
- Date Award
- May 13, 2024
- Vertical
- Biopharma
- Funding URL
- View Funding Page
Company Info
- Founders
- Melanie Matheu, Kevin Chapman, Yelda Kaya, Matt Niemiec
- Company Description
- Prellis is leveraging their unique approach to tissue engineering to support the first use of synthetic human tissue for de novo therapeutic antibody discovery.
- Market
- Human Health
- Location
-
United States
Links